112 related articles for article (PubMed ID: 16301357)
1. New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant.
Liu K; Yang T; Viswanathan PC; Roden DM
Circulation; 2005 Nov; 112(21):3239-46. PubMed ID: 16301357
[TBL] [Abstract][Full Text] [Related]
2. Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome.
Smits JP; Veldkamp MW; Bezzina CR; Bhuiyan ZA; Wedekind H; Schulze-Bahr E; Wilde AA
Cardiovasc Res; 2005 Aug; 67(3):459-66. PubMed ID: 16039271
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
4. Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome.
Huang H; Millat G; Rodriguez-Lafrasse C; Rousson R; Kugener B; Chevalier P; Chahine M
FEBS Lett; 2009 Mar; 583(5):890-6. PubMed ID: 19302788
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
[TBL] [Abstract][Full Text] [Related]
7. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
8. Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel.
Surber R; Hensellek S; Prochnau D; Werner GS; Benndorf K; Figulla HR; Zimmer T
Cardiovasc Res; 2008 Mar; 77(4):740-8. PubMed ID: 18065446
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of protein kinase C inhibits bursting in disease-linked mutant human cardiac sodium channels.
Tateyama M; Kurokawa J; Terrenoire C; Rivolta I; Kass RS
Circulation; 2003 Jul; 107(25):3216-22. PubMed ID: 12796143
[TBL] [Abstract][Full Text] [Related]
10. Gene symbol: SCN5A.
Crotti L; Ferrandi C; Insolia R; Pedrazzini M; Tosin L; Veia A; Turco A; De Ferrari GM; Schwartz PJ
Hum Genet; 2007 Feb; 120(6):911-2. PubMed ID: 17438607
[No Abstract] [Full Text] [Related]
11. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
12. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
13. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
[TBL] [Abstract][Full Text] [Related]
14. Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.
Clancy CE; Tateyama M; Liu H; Wehrens XH; Kass RS
Circulation; 2003 May; 107(17):2233-7. PubMed ID: 12695286
[TBL] [Abstract][Full Text] [Related]
15. SCN5A channelopathies--an update on mutations and mechanisms.
Zimmer T; Surber R
Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
[TBL] [Abstract][Full Text] [Related]
16. Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes.
Mank-Seymour AR; Richmond JL; Wood LS; Reynolds JM; Fan YT; Warnes GR; Milos PM; Thompson JF
Am Heart J; 2006 Dec; 152(6):1116-22. PubMed ID: 17161064
[TBL] [Abstract][Full Text] [Related]
17. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P
Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334
[TBL] [Abstract][Full Text] [Related]
18. Cardiac channelopathies: it's in the genes.
Ackerman MJ
Nat Med; 2004 May; 10(5):463-4. PubMed ID: 15122246
[No Abstract] [Full Text] [Related]
19. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
[TBL] [Abstract][Full Text] [Related]
20. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation.
Ye B; Valdivia CR; Ackerman MJ; Makielski JC
Physiol Genomics; 2003 Feb; 12(3):187-93. PubMed ID: 12454206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
